Q1 2018 Immune Design Corp Earnings Call
Conference Call Immune Design Corp
Immune Design Corp Conference call or earnings call will be held on May 2, 2018 via an 800 number (toll-free). During the earnings conference call's session Immune Design Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Immune Design Corp for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease. Although we believe our approaches have broad potential across multiple therapeutic areas, we are focused in oncology and have engineered our technologies to activate the immune system's natural ability to create tumor-specific cytotoxic T cells to fight cancer. Our two primary product candidates, CMB305 and G100, utilize distinct immuno-oncology approaches that, we believe, address the shortcomings of existing therapies and have the potential to treat a broad patient population either as individual therapies or in combination with other mechanisms of action. We have also been executing a strategy to partner individual indications outside of oncology in infectious and allergic diseases, which provide potential downstream economics while preserving growth opportunity in the future.Read more Conference Call